Inhibikase Therapeutics Inc Free Cash Flow Generation Index

Latest as of September 2020: 1.00x

Inhibikase Therapeutics Inc free cash flow generation index. Inhibikase Therapeutics Inc (IKT) has a Free Cash Flow Generation Index of 1.00x as of September 2020. Free cash flow of $75.52K represents 1% of operating cash flow ($75.52K).

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$75.52K
USD

Operating Cash Flow

$75.52K
USD

Capital Expenditures

$0.00
USD

Free Cash Flow Generation Index of Inhibikase Therapeutics Inc (2018–2018)

Free cash flow generation index of Inhibikase Therapeutics Inc from 2018 to 2018. Historical FCF Generation Index trend for Inhibikase Therapeutics Inc across 1 annual periods. See financial flexibility index of Inhibikase Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.

Inhibikase Therapeutics Inc Free Cash Flow Generation Index by Year (2018–2018)

Inhibikase Therapeutics Inc free cash flow generation index by year from 2018 to 2018. Year-by-year Free Cash Flow Generation Index for Inhibikase Therapeutics Inc. For the full cash flow conversion analysis, see IKT cash flow metrics.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2018 1.00x $714.99K $714.99K $0.00 —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).